Terms ending in 2039
Every in-force patent on Contraline, Inc.'s record whose computed term ends in 2039, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,383,421 | Contraceptive Devices In force · High confidence | Contraline, Inc. | In force | High confidence | |
| US 11,510,807 | Systems and Methods for Delivering Biomaterials In force · High confidence | Contraline, Inc. | In force | High confidence | |
| US 11,951,032 | Systems and Methods for Delivering Biomaterials In force · High confidence | Contraline, Inc. | In force | High confidence | |
| US 11,957,616 | Systems and Methods for Delivering Biomaterials In force · Medium confidence | Contraline, Inc. | In force | Medium confidence |
4 of 4 patents shown. Soonest term end first, then patent number.
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.